Pharmaceutical GxP Compliance Auditing Experts

QbD Auditing, Inc.
Home

Attention FDA Regulated Companies

  1. Are you a Biotech, Pharma or Medical Device company looking for funding, partnerships, acquisitions, grants, etc. from the investment community?
  2. Do you know what is necessary in order to market your company to attract investors versus the other companies?
  3. What is it that the investors look for in a company and how to present your advantages versus your competition?
  4. What company internal systems are needed to show investors that you have completed due diligence properly and have the "look and feel" of a viable company.
  5. Are your development programs (e.g. Design Control System) well documented and justified to support your findings and what is needed for scale-up and commercialization? 
  6. Are you a device company seeking to enter into the drug / device combination arena?  Do you have the depth in technical understanding to navigate through the regulations required of combination products?
  7. Are you a pharma/biotech company seeking to enter into the drug / device combination arena?  Do you have the necessary design control system in place?  Do you have the technical understanding to know what parts of the device regulations apply and how?
QbD Auditing Inc. can help you get there sooner

QbD Auditing Inc. can provide direction and support to smaller to mid sized companies to strategically and dynamically provide technical expertise that is needed to attract investors.

We at QbD Auditing Inc. have over 55 years of technical expertise in regulated industries (Biotech, Pharma & Medical Device) and can provide our knowledge to help you shorten the time to attract investors and “time to market”.  We have significant experience and expertise in drug / device combination product development, commercialization and the required regulatory process.

Why are these services important?

  • Shorten time to penetrate the investment community
  • Provides advantages over your competitors
  • Shows the investor that the company as well as the technical programs are well developed.
  • Get funding earlier to accelerate your research efforts
  • Provides creditability to the investment community